Neuland Laboratories Ltd. logo

Neuland Laboratories Ltd. (NEULANDLAB)

Market Closed
10 Aug, 10:00
XNSE XNSE
22,216. 00
-639
-2.7959%
154.97B Market Cap
30.06 P/E Ratio
10% Div Yield
88,421 Volume
0 Eps
22,855
Previous Close
Add Transaction
Day Range
22,123 23,054
Year Range
11,500 23,500
Want to track NEULANDLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Neuland Laboratories Ltd. (NEULANDLAB) Statistics

Valuation metrics

Market Cap 154.97B
Enterprise value 292.69B
Trailing P/E (ttm) 80.56
Forward P/E -
PEG ratio 2.02
Price/Sales (ttm) 14.49
Price/Book (mrq) 15.64
Enterprise Value/Revenue 14.47
Enterprise Value/EBITDA 48.41

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 192.01K
Average volume (90 days) 69.54K

Price summary

52-Week low 11,500
52-Week high 23,500
Beta -
50-Day moving average 18,959.89
200-Day moving average 15,673.57

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 34
Trailing annual dividend yield 0.0015%
5-Year annual dividend yield -
Payout ratio 0.04
Dividend Date 11 Aug 2026
Ex-Dividend Date 24 Jul 2026
Last split factor 523:500
Last split Date 13 Aug 2014

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.18%
Operating margin 0.24%

Operational effectiveness

Return on assets 0.12%
Return on equity 0.22%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1,576.76
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 283.71
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 276.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 2.09%
Book value per share (mrq) 1,461.01

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -